Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3AY4

Crystal structure of nonfucosylated Fc complexed with bis-glycosylated soluble form of Fc gamma receptor IIIa

3AY4 の概要
エントリーDOI10.2210/pdb3ay4/pdb
関連するPDBエントリー1E4K 1T83 1T89 2DTS 3AVE
分子名称Ig gamma-1 chain C region, Low affinity immunoglobulin gamma Fc region receptor III-A, beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (6 entities in total)
機能のキーワードimmune system, complex, fc fragment, igg, receptor, cd16, gamma
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数3
化学式量合計75844.47
構造登録者
Mizushima, T.,Takemoto, E.,Yagi, H.,Shibata-Koyama, M.,Isoda, Y.,Iida, S.,Satoh, M.,Kato, K. (登録日: 2011-04-28, 公開日: 2011-08-03, 最終更新日: 2024-10-23)
主引用文献Mizushima, T.,Yagi, H.,Takemoto, E.,Shibata-Koyama, M.,Isoda, Y.,Iida, S.,Masuda, K.,Satoh, M.,Kato, K.
Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans
Genes Cells, 16:1071-1080, 2011
Cited by
PubMed Abstract: Removal of the fucose residue from the N-glycans of the Fc portion of immunoglobulin G (IgG) results in a dramatic enhancement of antibody-dependent cellular cytotoxicity (ADCC) through improved affinity for Fcγ receptor IIIa (FcγRIIIa). Here, we present the 2.2-Å structure of the complex formed between nonfucosylated IgG1-Fc and a soluble form of FcγRIIIa (sFcγRIIIa) with two N-glycosylation sites. The crystal structure shows that one of the two N-glycans of sFcγRIIIa mediates the interaction with nonfucosylated Fc, thereby stabilizing the complex. However, fucosylation of the Fc N-glycans inhibits this interaction, because of steric hindrance, and furthermore, negatively affects the dynamics of the receptor binding site. Our results offer a structural basis for improvement in ADCC of therapeutic antibodies by defucosylation.
PubMed: 22023369
DOI: 10.1111/j.1365-2443.2011.01552.x
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.2 Å)
構造検証レポート
Validation report summary of 3ay4
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon